Impact of Early vs. Late Bebtelovimab Administration in a Nurse-Driven Program for Solid Organ Transplant Recipients with Mild-to-Moderate COVID-19: A Propensity Score Analysis [Board No. A112]

bebtelovimab (LY-CoV1404) - AbCellera, Eli Lilly

https://eppro01.ativ.me/web/page.php?page=Session&project=ATC23&id=P5925

S. Salto-Alejandre1; W. Cochran2; D. Brennan1; D. Rowe2; L. Boyer2; D. Carter2; L. Hartman2; K. Shagena2; K. Freed2; A. Yassine3; D. Ostrander1; C. Durand1; W. A. Werbel1; R. K. Avery1

May 9, 2023